MAPS, MDMA and PTSD

Oakland, California – On April 17, 2016, over 900 people from around the world joined the Multidisciplinary Association for Psychedelic Studies to celebrate three decades of advancements in psychedelic research and therapy. The fundraising goal was to support the Phase 3 clinical trials, which are essential to making MDMA-assisted psychotherapy a legal prescription treatment for post-traumatic stress disorder.

Continue Reading